Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes through targeted T-cell activation.